Prevalence of prescribing of different anti-diabetic medications as add-on therapy in patients with type 2 diabetes on metformin. *Other=Sum of prevalence.

Slides:

Advertisements

Similar presentations

Date of download: 9/17/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Insulin Therapy for Type 2 Diabetes Mellitus JAMA.

Advertisements

Associations between OHS/OKS and hospital readmission costs >12 months after THR. Costs are measured in 2014 pound sterling (£). Associations between OHS/OKS.

SGLT2 Inhibitors: What Do the Data Mean for My Patients?

Choosing glucose-lowering medication in those with established ASCVD, HF, and CKD. CV, cardiovascular; DPP-4i, dipeptidyl peptidase 4 inhibitor; GLP-1.

Number of local authorities (LAs) commissioning each service directly or indirectly (n=148) (*Flu vaccination data excludes the service commissioned across.

Mean expense per year on courses and conferences that trainees have not been reimbursed. Mean expense per year on courses and conferences that trainees.

Daily contribution (%) of sodium and potassium from major food groups among participants aged 8–12 years (n=517), which includes major food groups provided.

Distribution of the absolute percentage differences of each basal rate estimate to final basal rates. Distribution of the absolute percentage differences.

Antihyperglycemic therapy in type 2 diabetes: general recommendations

New Horizons in Adjunctive Type 1 Diabetes Management With SGLT Inhibitors.

Antihyperglycemic therapy in type 2 diabetes: general recommendations.

Bar charts comparing the results of ePROMs between patients who found the scores inadequately assessed their symptoms against all other patients leaving.

Toxicity spectra and rankings in the subgroup analysis based on each specific grade 1-5 adverse event and cancer type. Toxicity spectra and rankings in.

Scatter graph showing total work time equivalent of all specialist palliative care practitioners commissioned by the Clinical Commissioning Group (CCG)

(A) Indirectly age-sex-deprivation-ethnicity standardised procedure ratios for combined eye injection procedures (OPCS-4: C794 and C893) by CCG in England,

DSM-IV delirium prevalence, including the estimated delirium prevalence in the 31 patients that did not undergo delirium assessment following initial screening.

Scatter graph showing the total number of specialist palliative care beds commissioned compared with the estimated number of people with palliative care.

Estimated probability of successful quitting (quit attempt of longer than 1 year) by quit attempt number in the Ontario Tobacco Survey. Estimated probability.

Frequency of potential risk of hypoglycemia for each estimate method, defined as a percentage difference between the estimate and final basal rate. Frequency.

Distribution of the percentage differences of each basal rate estimate to final basal insulin rates. Distribution of the percentage differences of each.

Trending patterns of life expectancy by sex, SES quintile and remoteness, NSW, 2001–2012. Trending patterns of life expectancy by sex, SES quintile and.

Differences in life expectancy by SES, sex and remoteness, NSW, 2001 and Differences in life expectancy by SES, sex and remoteness, NSW, 2001 and.

Estimated changes in body mass index (difference in BMI) after October 2010 among nursery schoolchildren born between 2 April 2006 and 1 April 2007 in.

A schematic representation of the possible pairwise comparisons of adherence and persistence between different medication classes. A schematic representation.

Add-On Therapy to Insulin in T1DM Management

Trends in the relative contribution of each second-line diabetes medication class, by quarter, as a percent of all second-line prescribing, 2011–2015.

Gender differences in diabetes prevalence in 2009 in the general Portuguese population patients and in patients with CAP. Diabetes prevalence is higher.

Kaplan-Meier plot of incident CVD according to the treatment group over a 4-year period following intensification of diabetes therapy. Kaplan-Meier plot.

Decline in the risk of carotid occlusion with more intensive medical therapy. Decline in the risk of carotid occlusion with more intensive medical therapy.

Details of the most commonly nominated conditions for the most commonly nominated small animal (a) and large animal (b) species as outlined by 3982 veterinary.

1-year and 5-year survival rates by cancer type, stage and group, England, up to 2011– year and 5-year survival rates by cancer type, stage and.

by Melanie J Calvert, Richard J McManus, and Nick Freemantle

T2DM patients with HF may benefit from SGLT2 inhibitor therapy

Governance and information centre requirements prior to application approval. s251, section 251 of the NHS 2006 Act; ONS, Office for National Statistics;

Distribution of total possible savings (y-axis), showing how much total saving there would be if only those over £x per practice per month (x-axis) were.

Percentage of patients who had their pre-evening capillary blood glucose monitored at least once during their steroid therapy. Percentage of patients who.

Number of patients who would have benefitted from addition of ACE inhibitor (ACEi), beta blockers (BB) or optimal therapy (one or both of ACEi and BB)

Knowledge gaps in key risk factor numbers

Scatter graph showing total work time equivalent of all specialist palliative care practitioners commissioned by the Clinical Commissioning Group (CCG)

Affected and unaffected prefectures in northeast Japan

ORs of receiving metformin for outcome measures, including age, number of comorbidities, provider age, A1C level, history of CHF, and use of medications,

Box and whisker plot showing the estimated budget per person with palliative care needs (using the estimation that 0.75% of the population has palliative.

Difference in cumulative revision of knee constructs compared with a contemporary benchmark at 7 years in men aged between 55 years and 75 years, using.

Kaplan-Meier survival curve for all catheterisations.

Number of patients treated at clinics that followed up fewer than 10 patients (2013–2016) or 20 patients (2012) and proportion of patients followed up.

Factors associated with preparedness competency of public health inspectors from the qualitative analysis, which are grouped into three levels according.

Time trends in the number of monthly admissions throughout the study period. Time trends in the number of monthly admissions throughout the study period.

Bubble plot with a fitted meta-regression line of the log prevalence of commercial pad use by adolescent girls over time, 104 studies in India published.

Pooled estimate of relative risk and 95% CIs of colorectal cancer associated with metformin therapy based on four studies comprising 107,961 diabetic patients.

Prevalence of prescribing of different anti-diabetic medications among all patients with type 2 diabetes on treatment. *Other=Sum of prevalence of Acarbose,

Fig 4 Population level predicted proportions of cutaneous melanocytic biopsy interpretations that would be verified by the consensus reference panel or.

Antihyperglycemic therapy in adults with type 2 diabetes

Suggested implementation approach for the prevention of oral mucositis guideline recommendations (HSCT, haematopoietic stem cell transplantation; KGF,

Absolute survival probability (per cent who have not quit successfully) of reported quit attempts of longer than 1 year during the first 18 months of observation.

Showing (A) the reported activity of community midwifery teams in recommending and providing seasonal influenza vaccination to pregnant women and (B) the.

Eye position of positional nystagmus in the right-ear-down and left-ear-down head positions in patients with horizontal canal type of benign paroxysmal.

Fig 2 Predicted probabilities of being in each of the five change in substance use categories (change from baseline in average daily amount of main substance)

Status of tapering in the first year of follow-up.

Predicted survival curves for hip replacements for two male and two female hypothetical individuals with different levels of blood cobalt at 2 and 5 µg/l.

Themes of Positionality, Core Concepts, Social/Environmental Factors, and Paradigms/Theories/Models. *Indicates answers specifically from the third open-ended.

Distribution of product medicinal products without commercial interest (MPWCI) presentations (original list) studied due to the age of the marketing authorisation.

Determinants of moderate Cardiovascular Health Index Score (achieving three or more risk factor targets), stratified by region conventions as in figure.

Representativeness of linked cancer registry and dispensed prescription data as compared with cancer registry data alone, by key patient and tumour characteristics.

Health states and movement between health states in Markov model.

Estimated relative change in price of fruit and vegetable subgroups under each modelled Brexit scenario. Estimated relative change in price of fruit and.

(A) Percentage of patients achieving remission or response at week 12 or 24 after initiating ova therapy. (A) Percentage of patients achieving remission.

Average change in blood pressure (BP) from recruitment to 6-month postrecruitment in intervention and control patients >50 years included due to having.

Standardised patient wearing the obesity simulation suit used in the present study to represent a patient with type 2 diabetes and grade 2 obesity. The.

Number of hospital presentations for self-harm in Derby from 2003 to 2012 (inclusive) based on Multicentre Study data, Hospital Episode Statistics (HES)

Forest plot of the prevalence rates of acne according to region.

Presentation transcript:

Prevalence of prescribing of different anti-diabetic medications as add-on therapy in patients with type 2 diabetes on metformin. *Other=Sum of prevalence of Insulins, Acarbose, GLP-1 analogues, Meglitinides and SGLT-2 inhibitors. **For detailed figures on point estimates and CIs, please consult online supplementary appendix 5. Prevalence of prescribing of different anti-diabetic medications as add-on therapy in patients with type 2 diabetes on metformin. *Other=Sum of prevalence of Insulins, Acarbose, GLP-1 analogues, Meglitinides and SGLT-2 inhibitors. **For detailed figures on point estimates and CIs, please consult online supplementary appendix 5. Manuj Sharma et al. BMJ Open 2016;6:e010210 ©2016 by British Medical Journal Publishing Group